Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.07K Sell
81
-135
-63% -$4.8K ﹤0.01% 779
2026
Q1
$6.47K Buy
216
+135
+167% +$4.28K ﹤0.01% 643
2025
Q4
$2.36K Hold
81
﹤0.01% 624
2025
Q3
$2.11K Hold
81
﹤0.01% 646
2025
Q2
$1.82K Buy
81
+1
+1% +$21 ﹤0.01% 659
2025
Q1
$1.67K Buy
+80
New +$1.68K ﹤0.01% 665

Other funds holding IX

Brown, Lisle/Cummings's IX Position: Q2 2026 in Review

Brown, Lisle/Cummings reduced its ORIX (IX) stake by 63% in Q2 2026, selling an estimated $4.8K and leaving 81 shares worth $3.07K. The position accounts for ﹤0.01% of the portfolio, ranked #779.

Brown, Lisle/Cummings first reported a position in IX in Q1 2025 and has held it in 6 quarters since. The position peaked at $6.47K in Q1 2026. 320 funds tracked by Wall St. Rank hold IX as of Q2 2026.

  • Brown, Lisle/Cummings held 81 shares of ORIX worth $3.07K as of Q2 2026.
  • Brown, Lisle/Cummings sold 135 ORIX shares in Q2 2026, an estimated $4.8K.
  • ORIX made up ﹤0.01% of Brown, Lisle/Cummings's portfolio in Q2 2026, its #779 holding.
  • Brown, Lisle/Cummings first reported a position in ORIX in Q1 2025 and has held it in 6 quarters since.
  • Brown, Lisle/Cummings's ORIX position peaked at $6.47K in Q1 2026.
  • 320 funds tracked by Wall St. Rank held ORIX as of Q2 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q2 2026, filed 2 Sep 2026.